Kiora Pharmaceuticals (KPRX) Receivables - Other (2015 - 2026)
Kiora Pharmaceuticals' (KPRX) quarterly Receivables - Other came in at $235647.0 in Q1 2026, down 46.82% YoY from $443122.0 in Q1 2025, and down 46.82% on a QoQ basis from $443122.0 in Q1 2025.
Kiora Pharmaceuticals (KPRX) Receivables - Other (2015 - 2026) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 6 years of Receivables - Other data on file, last reported at $235647.0 in Q1 2026.
- Quarterly Receivables - Other fell 46.82% year-over-year to $235647.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $678769.0 (up 53.18% YoY) and the FY2017 annual result came in at -$37349.0, up 98.84% from the prior year.
- Receivables - Other eased to $235647.0 in Q1 2026, from $443122.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $443122.0 in Q1 2025 to a low of $235647.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - |
| 10 | Kiora Pharmaceuticals | 15.97 Mn | 15.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91,340.00 |
| Jun 30, 2026 | -91,340.00 |
| Mar 31, 2026 | 235,647.00 |
| Mar 31, 2026 | 235,647.00 |
| Mar 31, 2025 | 443,122.00 |
| Mar 31, 2025 | 443,122.00 |
| Mar 31, 2018 | 922,488.00 |
| Mar 31, 2018 | 922,488.00 |
| Dec 31, 2017 | -601,999.00 |
| Dec 31, 2017 | -601,999.00 |
| Sep 30, 2017 | 602,000.00 |
| Sep 30, 2017 | 602,000.00 |
| Jun 30, 2017 | 146,078.00 |
| Jun 30, 2017 | 146,078.00 |
| Mar 31, 2017 | -3.93 Mn |
| Mar 31, 2017 | -3.93 Mn |
| Dec 31, 2016 | -855,001.00 |
| Dec 31, 2016 | -855,001.00 |
| Sep 30, 2016 | 37,350.00 |
| Sep 30, 2016 | 37,350.00 |